Progress, prospects, and problems in Epstein-Barr virus vaccine development.
Progress, prospects, and problems in Epstein-Barr virus vaccine development.
复制标题
DOI:
10.1016/j.coviro.2014.02.005
复制
发表时间:
2014-06
影响因子:
5.9
通讯作者:
Balfour, Henry H., Jr.
中科院分区:
文献类型:
--
作者:
Balfour, Henry H., Jr.
Epstein-Barr virus (EBV) is responsible for a farrago of acute and chronic human diseases including cancer. A prophylactic vaccine could reduce this disease burden. Several EBV vaccines have been given to humans but none has been sufficiently studied to establish safety and efficacy. EBV vaccine development has been hampered by the lack of an animal model other than subhuman primates, proprietary issues, selection of an appropriate adjuvant, and failure to reach consensus on what an EBV vaccine could or should actually achieve. A recent conference at the U.S. National Institutes of Health emphasizing the global importance of EBV vaccine and advocating a phase 3 trial to prevent infectious mononucleosis should encourage research that could eventually lead to its licensure.
登录
查看更多内容
影响因子:
6.7
作者:
Sashihara J;Hoshino Y;Bowman JJ;Krogmann T;Burbelo PD;Coffield VM;Kamrud K;Cohen JI
通讯作者:
Cohen JI
DOI:
10.1177/1352458511408991
发表时间:
2011-10
期刊:
Multiple sclerosis (Houndmills, Basingstoke, England)
影响因子:
--
作者:
Munger KL;Levin LI;O'Reilly EJ;Falk KI;Ascherio A
通讯作者:
Ascherio A
影响因子:
6.7
作者:
Angelini DF;Serafini B;Piras E;Severa M;Coccia EM;Rosicarelli B;Ruggieri S;Gasperini C;Buttari F;Centonze D;Mechelli R;Salvetti M;Borsellino G;Aloisi F;Battistini L
通讯作者:
Battistini L
影响因子:
6.4
作者:
Rainey, Jeanette J.;Omenah, Dorine;Wilson, Mark L.
通讯作者:
Wilson, Mark L.
DOI:
10.1056/nejmoa0706383
发表时间:
2008-02-14
期刊:
The New England journal of medicine
影响因子:
--
作者:
Hauser, Stephen L;Waubant, Emmanuelle;Smith, Craig H
通讯作者:
Smith, Craig H